BofA analyst Sherif El-Sabbahy raised the firm’s price target on Legence (LGN) to $62 from $55 and keeps a Buy rating on the shares after the company reported what the firm calls “a second set of solid results as a public firm.” The firm raised its topline estimates 9% on the updated outlook, while its EBITDA estimates increase 10%-14%, the analyst noted.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN: